Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$0.72 - $0.95 $185 - $245
-258 Reduced 3.61%
6,884 $5,000
Q4 2021

Apr 04, 2022

BUY
$0.95 - $1.69 $6,784 - $12,069
7,142 New
7,142 $51 Million

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0

About vTv Therapeutics Inc.


  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.33B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Strengthening Families & Communities, LLC Portfolio

Follow Strengthening Families & Communities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strengthening Families & Communities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strengthening Families & Communities, LLC with notifications on news.